METASTATIC POTENTIAL OF HUMAN COLON CANCER CELL-LINES - RELATIONSHIP TO CELLULAR-DIFFERENTIATION AND CARCINOEMBRYONIC ANTIGEN PRODUCTION

被引:83
|
作者
WAGNER, HE
TOTH, CA
STEELE, GD
THOMAS, P
机构
[1] NEW ENGLAND DEACONESS HOSP,DEPT SURG,CANC BIOL LAB,50 BINNEY ST,BOSTON,MA 02215
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
HUMAN COLORECTAL CANCER; NUDE MOUSE; CARCINOEMBRYONIC ANTIGEN; DIFFERENTIATION; METASTASIS; LIVER AND LUNG;
D O I
10.1007/BF00163573
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between cellular differentiation and carcinoembryonic antigen (CEA) production by human colorectal tumor cells and their ability to form hepatic metastases was studied. Eight human colon cancer cell lines were injected into thymic mice using different routes of administration to characterize their metastatic potential. The four poorly differentiated, non or low CEA producing cell lines were poorly metastatic to the liver after intrasplenic injection. After intraperitoneal implantation the same cell lines were highly tumorigenic, and subsequently metastastic to the liver. In contrast, the four moderate to well-differentiated cell lines that produced moderate to high levels of CEA were highly metastatic to the liver following intrasplenic injection. After intraperitoneal implantation they were less tumorigenic, and metastatic to the liver. We conclude that in this system poorly differentiated non or low CEA producing colorectal cell lines have a lower metastatic capacity compared to the well-differentiated high CEA producing colorectal cell lines. These data correlate directly with the pattern of metastatic spread and clinical course observed in patients with these tumors, suggesting that degree of differentiation and level of CEA production may play a role in development of site-specific metastases.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [31] DIFFERENTIATION STATE AND INVASIVENESS OF HUMAN BREAST-CANCER CELL-LINES
    SOMMERS, CL
    BYERS, SW
    THOMPSON, EW
    TORRI, JA
    GELMANN, EP
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 31 (2-3) : 325 - 335
  • [32] DIFFERENCES IN PRODUCTION OF EGF-LIKE ACTIVITY IN HUMAN-COLON CARCINOMA CELL-LINES ARE RELATED TO THE DEGREE OF DIFFERENTIATION
    WATKINS, LF
    LEVINE, AE
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 115 - 115
  • [33] ADHESION CHARACTERISTICS OF HUMAN-MELANOMA CELL-LINES OF VARYING METASTATIC POTENTIAL
    ORMEROD, EJ
    EVERETT, CA
    HART, IR
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) : 150 - 154
  • [34] HUMAN-COLON CANCER AND FIBROBLAST CELL-LINES CULTURED IN AND ON COLLAGEN GELS
    AGREZ, MV
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1989, 59 (05): : 415 - 420
  • [35] EFFECT OF SELENIUM ON THE GROWTH OF 3 HUMAN-COLON CANCER CELL-LINES
    NANO, JL
    CZERUCKA, D
    MENGUY, F
    RAMPAL, P
    BIOLOGICAL TRACE ELEMENT RESEARCH, 1989, 20 (1-2) : 31 - 43
  • [36] Cell cycle exit and in vitro differentiation of human colon cancer cell lines
    Mayol, X
    Redón, M
    Real, FX
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S25 - S25
  • [37] VARIANTS OF A HUMAN COLON ADENOCARCINOMA CELL LINE WHICH DIFFER IN MORPHOLOGY AND CARCINOEMBRYONIC ANTIGEN PRODUCTION
    ROSENTHAL, KL
    TOMPKINS, WAF
    FRANK, GL
    MCCULLOCH, P
    RAWLS, WE
    CANCER RESEARCH, 1977, 37 (11) : 4024 - 4030
  • [38] Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis
    Ilantzis, C
    Jothy, S
    Apert, LC
    Draber, P
    Stanners, CP
    LABORATORY INVESTIGATION, 1997, 76 (05) : 703 - 716
  • [39] SULFATED GLYCOCONJUGATES PRODUCED BY HUMAN-COLON CARCINOMA CELL-LINES WITH DIFFERENT METASTATIC POTENTIALS
    YAMORI, T
    IRIMURA, T
    OTA, DM
    CLEARY, KR
    GIAVAZZI, R
    FIDLER, IJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 63 - 63
  • [40] The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells
    Sato, M
    Narita, T
    Kimura, N
    Zenita, K
    Hashimoto, T
    Manabe, T
    Kannagi, R
    ANTICANCER RESEARCH, 1997, 17 (5A) : 3505 - 3511